EIDOS THERAPEUTICS, INC. Comprehensive Income
EIDOS THERAPEUTICS, INC. reported Comprehensive Income of -$37.84 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-26.
Discontinued › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2020-02-26
- EIDOS THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-12-31 was -$18.98M.
- EIDOS THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-09-30 was $6.93M.
- EIDOS THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-06-30 was -$14.05M.
- EIDOS THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-03-31 was -$11.73M.
- EIDOS THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was -$37.84M.
- EIDOS THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$40.73M.
- EIDOS THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was -$11.94M.
- EIDOS THERAPEUTICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2016 was -$2.54M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$18.98M derived: 10-K 12 month − 3 quarters · filed 2020-02-26 | -$12.05M derived: sum of 2 quarters · filed 2020-02-26 | -$26.10M derived: sum of 3 quarters · filed 2020-02-26 | -$37.84M 10-K · filed 2020-02-26 |
| 2019-09-30 | $6.93M 10-Q · filed 2019-10-31 | -$7.12M derived: sum of 2 quarters · filed 2019-10-31 | -$18.86M derived: sum of 3 quarters · filed 2019-10-31 | |
| 2019-06-30 | -$14.05M 10-Q · filed 2019-10-31 | -$25.79M derived: sum of 2 quarters · filed 2019-10-31 | ||
| 2019-03-31 | -$11.73M 10-Q · filed 2019-10-31 | |||
| 2018-12-31 | -$40.73M 10-K · filed 2020-02-26 | |||
| 2018-09-30 | -$10.61M 10-Q · filed 2019-10-31 | -$21.99M derived: sum of 2 quarters · filed 2019-10-31 | -$30.87M derived: sum of 3 quarters · filed 2019-10-31 | |
| 2018-06-30 | -$11.38M 10-Q · filed 2019-10-31 | -$20.26M derived: sum of 2 quarters · filed 2019-10-31 | ||
| 2018-03-31 | -$8.88M 10-Q · filed 2019-10-31 | |||
| 2017-12-31 | -$11.94M 10-K · filed 2020-02-26 | |||
| 2016-12-31 | -$2.54M 10-K · filed 2019-04-15 |